Lancet
-
Randomized Controlled Trial Multicenter Study
Deep learning for prediction of colorectal cancer outcome: a discovery and validation study.
Improved markers of prognosis are needed to stratify patients with early-stage colorectal cancer to refine selection of adjuvant therapy. The aim of the present study was to develop a biomarker of patient outcome after primary colorectal cancer resection by directly analysing scanned conventional haematoxylin and eosin stained sections using deep learning. ⋯ The Research Council of Norway.